Chemoinformaics analysis of Cyanidin-3-Beta-L-Arabinoside
| Molecular Weight | 454.815 | nRot | 3 |
| Heavy Atom Molecular Weight | 435.663 | nRig | 23 |
| Exact Molecular Weight | 454.067 | nRing | 4 |
| Solubility: LogS | -3.787 | nHRing | 2 |
| Solubility: LogP | 0.915 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 56.2691 |
| nHD | 7 | BPOL | 24.2689 |
| QED | 0.24 |
| Synth | 4.192 |
| Natural Product Likeliness | 1.991 |
| NR-PPAR-gamma | 0.946 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.829 |
| HIA | 0.729 |
| CACO-2 | -6.286 |
| MDCK | 0.00000472 |
| BBB | 0.041 |
| PPB | 0.911414 |
| VDSS | 0.834 |
| FU | 0.130399 |
| CYP1A2-inh | 0.15 |
| CYP1A2-sub | 0.054 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.191 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.205 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.014 |
| CL | 9.635 |
| T12 | 0.85 |
| hERG | 0.011 |
| Ames | 0.786 |
| ROA | 0.074 |
| SkinSen | 0.481 |
| Carcinogencity | 0.171 |
| EI | 0.401 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.935 |
| Antiviral | Yes |
| Prediction | 0.616155 |